Korean Obesity drugs stocks
GLP-1 obesity treatments — development stages, licensing deals and contract manufacturing at Korean pharma and biotech companies.
Most-mentioned Obesity drugs companies 2 weeks
| # | Company | Market | Articles | Share | Last mention |
|---|---|---|---|---|---|
| 1 | Hanmi Pharm 128940 | KOSPI | 1 | 25.0% | 07:47 |
| 2 | PharmaResearch 214450 | KOSDAQ | 1 | 25.0% | Sep 11 16:51 |
| 3 | G2gbio 456160 | KOSDAQ | 1 | 25.0% | 10:23 |
| 4 | Chong Kun Dang Pharmaceutical 185750 | KOSPI | 1 | 25.0% | Sep 14 19:26 |
| 5 | OliX Pharmaceuticals 226950 | KOSDAQ | 1 | 25.0% | Sep 14 19:26 |
Roundup articles listing five or more companies are excluded. A mention is not a recommendation.
Top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
